News

< Back

Grantee in the News: Reisa Sperling on Research Showing Difference in Alzheimer’s by Race

On July 15th, Healthday.com featured comments by 2000 Beeson Scholar Dr. Reisa Sperling on new research showing differences in the patterns of Alzheimer’s disease development among African American and Caucasian individuals.

Researchers found that among those deceased due to Alzheimer’s disease, only 20 percent of African American individuals exhibited typical Alzheimer’s, as compared to 41 percent of whites. Dr. Sperling, is currently working on improving racial disparities among clinical trial participants , and notes that while this finding may offer insight into why African Americans are two-times for likely than white Americans to develop Alzheimer’s disease, more research is needed to determine when these brain changes begin.

This article was also picked up by US News and World Reports; Philly.com; and Newsmax Health.

Reisa Sperling, MD, MMSc, is the Director, Center for Alzheimer's Research and Treatment & Co-Director, Neuroimaging Core at the Massachusetts Alzheimer's Disease Research Center and a Professor of Neurology at Harvard Medical School.

For more information on the genetics behind Alzheimer’s disease, download our InfoAging guide here.

More Recent News

View All News >
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD , on “Why Do We Age?” in The New York Times
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD , on “Why Do We Age?” in The New York Times
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Grantee in the News: Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Grantee in the News:  Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Marc Weksler, MD, former AFAR Board President